Clonz Biotech Pvt Ltd

We are very focused on the knowledge pool and people perspective that is central to both increasing our understanding on MABs and building accessible biologics for a wider global market. At Clonz we are specialists in bioengineering and creating biosimilars that improve accessibility for patients. Clonz Biotech was founded in 2010 by an experienced team of recognized leaders in biosimilar research and manufacturing. We operate from Genome Valley, Hyderabad, India to exclusively focus on developing the biosimilar therapeutic monoclonal antibodies (MABs). The manufacture of MABs is highly complex, requiring exceptional experience and tenacity. To achieve this we employ in house clone/product development with complete understanding and control over processes to ensure robust manufacturing. As a result of our commitment to helping patients lives, we develop products, processes that give excellent yields, purity and are remarkably efficient compared to some larger less specifically MABs focussed organizations. Efficiency/speed of mass production is essential to the strategy here at Clonz.